COVALON TECHNOLOGIES LTD (COV.CA) Stock Price, Quote, News and Overview
TSX-V:COV - TSX Venture Exchange - CA22282D3022 - Common Stock - Currency: CAD
COV.CA Quote, Performance and Key Statistics
TSX-V:COV (6/13/2025, 7:00:00 PM)
2.33
0 (0%)
The current stock price of COV.CA is 2.33 CAD. In the past month the price decreased by -8.63%. In the past year, price increased by 17.09%.
COV.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 297.19M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 250.91M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 191.80M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 156.33M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 72.83M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 70.40M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 59.60M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 54.18M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 49.31M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 43.27M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 30.5 | 42.94M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 25.83M |
Related stock screener links
About COV.CA
Company Profile
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
Company Info
COVALON TECHNOLOGIES LTD
1660 Tech Avenue, Unit 5
Mississauga ONTARIO L4W 5S7 CA
CEO: Simon Smith
Employees: 41
Phone: 18777116055
COVALON TECHNOLOGIES LTD / COV.CA FAQ
What is the stock price of COVALON TECHNOLOGIES LTD today?
The current stock price of COV.CA is 2.33 CAD.
What is the ticker symbol for COVALON TECHNOLOGIES LTD stock?
The exchange symbol of COVALON TECHNOLOGIES LTD is COV and it is listed on the TSX Venture Exchange exchange.
On which exchange is COV.CA stock listed?
COV.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for COVALON TECHNOLOGIES LTD stock?
9 analysts have analysed COV.CA and the average price target is 3.83 CAD. This implies a price increase of 64.16% is expected in the next year compared to the current price of 2.33. Check the COVALON TECHNOLOGIES LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COVALON TECHNOLOGIES LTD worth?
COVALON TECHNOLOGIES LTD (COV.CA) has a market capitalization of 63.89M CAD. This makes COV.CA a Micro Cap stock.
How many employees does COVALON TECHNOLOGIES LTD have?
COVALON TECHNOLOGIES LTD (COV.CA) currently has 41 employees.
What are the support and resistance levels for COVALON TECHNOLOGIES LTD (COV.CA) stock?
COVALON TECHNOLOGIES LTD (COV.CA) has a support level at 2.26 and a resistance level at 2.34. Check the full technical report for a detailed analysis of COV.CA support and resistance levels.
Is COVALON TECHNOLOGIES LTD (COV.CA) expected to grow?
The Revenue of COVALON TECHNOLOGIES LTD (COV.CA) is expected to grow by 14.26% in the next year. Check the estimates tab for more information on the COV.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy COVALON TECHNOLOGIES LTD (COV.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of COV.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of COV.CA, evaluating the profitability, health, valuation and growth aspects
- COVALON TECHNOLOGIES LTD (COV.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COVALON TECHNOLOGIES LTD (COV.CA) Sales and EPS estimates to see what analysts future expectations are.
- COVALON TECHNOLOGIES LTD (COV.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COVALON TECHNOLOGIES LTD (COV.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- COVALON TECHNOLOGIES LTD (COV.CA) Stock Chart to make your own analysis
- COVALON TECHNOLOGIES LTD (COV.CA) Latest news and press-releases to stay up to date.
Does COVALON TECHNOLOGIES LTD (COV.CA) stock pay dividends?
COV.CA does not pay a dividend.
When does COVALON TECHNOLOGIES LTD (COV.CA) report earnings?
COVALON TECHNOLOGIES LTD (COV.CA) will report earnings on 2025-08-19.
What is the Price/Earnings (PE) ratio of COVALON TECHNOLOGIES LTD (COV.CA)?
The PE ratio for COVALON TECHNOLOGIES LTD (COV.CA) is 17.92. This is based on the reported non-GAAP earnings per share of 0.13 and the current share price of 2.33 CAD. Check the full fundamental report for a full analysis of the valuation metrics for COV.CA.
COV.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to COV.CA. When comparing the yearly performance of all stocks, COV.CA turns out to be only a medium performer in the overall market: it outperformed 60.88% of all stocks.
COV.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to COV.CA. COV.CA gets an excellent profitability rating and is at the same time showing great financial health properties.
COV.CA Financial Highlights
Over the last trailing twelve months COV.CA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 225.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.92% | ||
| ROA | 10.52% | ||
| ROE | 11.87% | ||
| Debt/Equity | 0 |
COV.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to COV.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -30.77% and a revenue growth 14.26% for COV.CA